In the present study, we demonstrated that PCI34051, an HDAC8-selective inhibitor, lowered systolic blood pressure, reduced aortic wall thickness, increased vascular relaxation, and inhibited inflammation in a mouse model of Ang II-induced hypertension. Here, AGT is linked to hypertensive disorder.